Fig. 1 · Structure

Documents & Downloads

Apremilast (CC 10004)

Cat. No. A11289 CAS 608141-41-9

PDE4 Inhibitor

Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis.

In Stock

Publications for Apremilast

2 publications citing this product

  1. Tomoaki Higuchi, .et al. , Sci Rep, 2023, Nov 8;13(1):19378 PMID: 37938601
  2. Higuchi T, .et al. , Research Square, 2023, Mar 02

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
PDE4 IC50 74 nM

Cellular Effect

Cell Line Activity Value Description Reference
PBMC IC50 0.077 μM Inhibition of TNFalpha production in LPS-stimulated human PBMC preincubated before LPS challenge measured after 4 hrs by enzyme immunoassay [PMID: 19256507]
Sf9 IC50 21 nM Inhibition of recombinant human His6-tagged PDE4D UCR2 deletion mutant catalytic domain expressed in baculovirus infected Sf9 insect cells using cAMP as substrate preincubated for 5 to 10 mins followed by substrate addition and measured for 10 mins by yea [PMID: 31013090]
Sf9 IC50 23 nM Inhibition of recombinant human His6-tagged PDE4D3 UCR1 S54D mutant expressed in baculovirus infected Sf9 insect cells using cAMP as substrate preincubated for 5 to 10 mins followed by substrate addition and measured for 10 mins by yeast myokinase/pyruvat [PMID: 31013090]
Sf9 IC50 24 nM Inhibition of recombinant human His6-tagged PDE4B1 UCR1 S133D mutant expressed in baculovirus infected Sf9 insect cells using cAMP as substrate preincubated for 5 to 10 mins followed by substrate addition and measured for 10 mins by yeast myokinase/pyruva [PMID: 31013090]
Sf9 IC50 26 nM Inhibition of recombinant human His6-tagged PDE4D7 UCR1 S129D mutant expressed in baculovirus infected Sf9 insect cells using cAMP as substrate preincubated for 5 to 10 mins followed by substrate addition and measured for 10 mins by yeast myokinase/pyruva [PMID: 31013090]
Sf9 IC50 32 nM Inhibition of recombinant human wild-type His6-tagged PDE4D7 UCR1 domain (S129 residues) expressed in baculovirus infected Sf9 insect cells using cAMP as substrate preincubated for 5 to 10 mins followed by substrate addition and measured for 10 mins by ye [PMID: 31013090]
Sf9 IC50 35 nM Inhibition of recombinant human His6-tagged PDE4D2 expressed in baculovirus infected Sf9 insect cells using cAMP as substrate preincubated for 5 to 10 mins followed by substrate addition and measured for 10 mins by yeast myokinase/pyruvate kinase/lactate [PMID: 31013090]

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 608141-41-9
Applications PDE4 Inhibitor
Formula C22H24N2O7S
Molecular Weight 460.5
Synonyms CC10004
SMILES
CCOC1=C(C=CC(=C1)[C@@H](CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 85 mg/mL (184.58 mM)
Water Insoluble
Ethanol Insoluble

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

In Vivo Preparation

Concentration
28 mg/mL
Vehicle
0.5% CMC+0.25% Tween 80

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Publications

2 publications citing this product

  1. Tomoaki Higuchi, .et al. , Sci Rep, 2023, Nov 8;13(1):19378 PMID: 37938601
  2. Higuchi T, .et al. , Research Square, 2023, Mar 02

Added to your cart

View Cart Checkout
Loading...